BioSpace News Archive

Dental Implant Market to Exceed $3 Billion in U.S. and Europe by 2023

According to the latest series of reports by iData Research, the United States and Europe market for dental implants and computer-guided surgery is estimated to reach $2.4 billion USD in 2018.

September 6, 2018
·
2 min read
Policy

NeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development Plan

NeuroVive Pharmaceutical AB today announced positive U.S. Food and Drug Administration (FDA) feedback on its NeuroSTAT clinical development plan for the treatment of moderate to severe Traumatic Brain Injury (TBI) at a pre-IND (Investigational New Drug) meeting.

September 6, 2018
·
4 min read
Business

Perlara announces MPSIII PerlQuests with Cure Sanfilippo Foundation

Perlara today announced a Mucopolysaccharidosis Type IIIA and Type IIIB PerlQuest partnership with Cure Sanfilippo Foundation, a South Carolina-based 501(c)(3) not-for-profit organization funding research to develop treatments and a cure for Sanfilippo Syndrome.

September 6, 2018
·
3 min read
Drug Development

PvP Biologics Announces First-in-Human Clinical Trials for a Novel Therapeutic for Celiac Disease

Kuma062 is a uniquely engineered, recombinant enzyme that is active under acidic stomach conditions and has high specificity for the parts of gluten that cause the autoimmune reaction leading to celiac disease.

September 6, 2018
·
3 min read
Policy

UPDATE - Media Advisory - Minister Philpott to visit Winnipeg and make announcements regarding First Nations education and health transformation

The location has been updated

September 6, 2018
·
1 min read
Biotech Bay

CrossFit Takes on Childhood Chronic Disease with Community Workout, “Saved by the Barbell”

Saved by the Barbell is an annual, worldwide CrossFit community Labor Day workout and fundraising effort to bring CrossFit to more kids everywhere.

September 6, 2018
·
19 min read
Drug Development

Neumentum Announces Dosing of Patients in Phase I Study Evaluating Its Lead Product Candidate, NTM-001, a Non-Opioid in Development for the Management of Moderately Severe Acute Pain

Potential to be the First Continuously Infused NSAID to be Successfully Developed for Acute Post-Operative Pain in the US

September 6, 2018
·
4 min read
FDA

The Familial Chylomicronemia Syndrome Foundation Implores FDA To Approve Much Needed Therapy

Rare disease community left without an approved treatment option despite success in clinical trials

September 6, 2018
·
3 min read
BioForest

United States Tennis Association Pacific Northwest Opens Two Public Indoor Tennis Facilities In Washington This Week

Galbraith Tennis Center in Tacoma and Vancouver Tennis Center provide industry best indoor public courts, serve region’s groundswell of interest in tennis

September 6, 2018
·
2 min read
Job Trends

NMI® at 58.5%; August Non-Manufacturing ISM® Report On Business®

Business Activity Index at 60.7%; New Orders Index at 60.4%; Employment Index at 56.7%

September 6, 2018
·
28 min read